Introduction
Audiogenic seizures, representing a generalized form of the reflex epilepsy, express typical signs Seizure (2005) 
Summary
Problem: Previous studies have shown that humoral, endogenous and somnogenic, delta sleep-inducing peptide (DSIP) has influence on insomnia, pain, adaptation to stress, epilepsy, etc. We investigated the potential of DSIP and its analogue DSIP À12 (a nonapeptide with alanine in position 2 of DSIP molecule substituted by b-alanine) to antagonize metaphit (1-[1(3-isothiocyanatophenyl)-cyclohexyl]piperidine) induced generalized, reflex audiogenic seizures in adult male Wistar albino rats. Methods: The rats divided in four groups received (i.p.): saline; metaphit; metaphit + DSIP; and metaphit + DSIP À12 , respectively. Metaphit-treated animals displaying seizure in eight previous tests received DSIP or DSIP À12 and afterwards audiogenic stimuli were applied at hourly intervals for the next 30 h. The animals were exposed to sound stimulation 60 min after metaphit administration and further on at hourly intervals. Incidence and severity of seizures were behaviorally analyzed. Selected EEGs and power spectra were recorded and analyzed. Results and conclusions: Metaphit led to hypersynchronous epileptiform activity (polyspikes and spike-wave complexes) and increased power spectra 0.5-30 h after the treatment. Severity of metaphit seizures increased with time to reach the peak 7-12 h after injection. DSIP and DSIP À12 significantly ( * P < 0.05 and ** P < 0.01) increased in d and u frequency bands and decreased the incidence, mean seizure grade and duration of metaphit convulsions. The results suggest that DSIP and DSIP À12 may be considered as potential antiepileptics in the animal model, DSIP À12 being more efficient than DSIP. # 2005 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved. Figure 1 The evolution of EEG changes in one particular metaphit-treated animal (10 mg/kg, i.p.). Spiking of large amplitude and high frequency and their progression into multiple spikes (upper tracings). Power spectra of the corresponding EEG activity started to increase (bottom). Numbers in the lower parts of the figure refer to the absolute power (mV 2 ) of the d, u, a, b1, b2, bands and of the total (Tot) spectra. LFO: left frontooccipital cortex. Metaphit was shown to increase general brain excitability and to induce audiogenic seizures in small rodents. 4, 5 Upon the discovery of the delta sleep-inducing factor (DSIP) in human fluids, 6 ,7 numerous authors reported a broad array of its physiological effects in addition to somnogenic action. [7] [8] [9] [10] [11] [12] [13] [14] Based on structure-activity relationship studies aimed at improvement of DSIP action, increased stability against proteolysis and improved lipophilicity, a series of its analogues were synthesized by replacing amino acids in position 1, 2 or 6 of the native peptide. 7, 8 Our study has been conducted on rats expressing generalized audiogenic reflex epilepsy induced by the metaphit. The blocking effects of somnogenic nonapeptide DSIP and its analogue DSIP À12 (nonapeptide with alanine in position 2 of DSIP molecule substituted by b-alanine) in metaphit-induced epilepsy in rats were studied with an aim of shedding more light on their mechanism of action and answer-242 O.P. Stanojlović et al. Table 1 Time course of metaphit-induced seizure components and blocking effects of DSIP and DSIP À12 in rats. ing the question whether DSIP and DSIP À12 could be used as antiepileptic agents.
Material and methods
All experiments were performed at the Neurophysiological Laboratory, Institute of Physiology, School of Medicine, University of Belgrade. Adult male Wistar albino rats weighing 180-200 g (Military Medical Academy Breeding Laboratories, Belgrade) were used. The animals were maintained at ambient temperature (21 AE 2 8C and 12/12-h light/dark cycle with light switched on at 09:00 h). They were housed individually in transparent plastic cages with food and water ad libitum. None of the animals screened for audiogenic susceptibility showed seizure activity. Audiogenic stimulation (AGS) has been applied for 60 s using an electric bell (on the top of the cage) generating 100 AE 3 dB at frequency of 5-8 kHz. The first stimulation was applied 1 h after metaphit administration and repeated afterwards at hourly intervals during the experiment. Audiogenic convulsive behavior was assessed by incidence of motor seizure and seizure severity grade, presented (as previously reported 1,2,14 ) using three-degree descriptive rating scale (0: no response; 1: wild running; 2: wild running followed by clonic seizures; 3: wild running progressing to generalized clonic and then tonic extension of fore and hind limbs and tail).
The rats were divided into four groups: salineinjected controls (n = 6); metaphit-administered (mp: 10 mg/kg; n = 12); metaphit + DSIP (D: 0.4 mg/kg; n = 9) and metaphit + DSIP À12 (A: 0.4 mg/kg; n = 9). This time-course study revealed that the peak of metaphit-induced convulsive activity (10 mg/kg, i.p.), occurs 8-12 h after the injection. Metaphit-treated animals displaying seizures in eight previous tests had received DSIP or its analogue and afterwards audiogenic stimuli (AGS) were applied at hourly intervals for next 30 h. The third and fourth groups consisted of smaller number of animals than the second group, because all those animals that did not show peak incidence of metaphit-induced epilepsy after eight tests were excluded. Injection solutions were prepared in sterile physiological saline immediately before administration. All treatments were performed via i.p. route employing injection volume of 0.1 ml.
For the EEG recordings three gold-plated screws were implanted into the skull over frontal, parietal and occipital cortices. From these bilateral electrode placements, recordings were taken ipsilaterally and bilaterally. The rats were anesthetized with sodium pentobarbital (40 mg/kg, i.p.), positioned in a stereotaxic apparatus and three gold-plated recording electrodes were implanted over frontal, parietal and occipital cortices. EEG apparatus (Alvar, France) with a modified output degree enabling transfer of output signals to the input circuit of 8-channel, 12-bit AD card PCL-711B (Advantech Co. Ltd., Taiwan, ROC) installed into computer and the corresponding software used. Length 
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Results
In saline-injected control animals, behavior and EEG tracing showed no signs of convulsive activity in response to audiogenic stimuli. Metaphit injection produced the changes in EEG after 0.5-1 h seen as sporadic isolated waves. EEG and behavioral seizures were elicited by AGS forming a series of polyspikes, synchronized spikes and fast high-voltage and low frequency activities that represent typical seizure manifestations. The rats displayed wild running after a latency period that evolved into generalized clonic convulsions and the most severe tonic convulsions when EEG power spectra increased 244 O.P. Stanojlović et al. and became more intense (Fig. 1) . The peak of metaphit-induced convulsive activity was recorded 8-12 h after the injection judged by the intensity, high incidence and severity (Fig. 2) . Epilepsy observed in animals abated gradually and disappeared 30 h later. About 25% of metaphit-treated animals (10 mg/kg, i.p.) that never responded to AGS and behaved normally during this critical time period were excluded from the experiments.
Incidence of convulsive response in metaphit + DSIP and metaphit + DSIP À12 groups
Only metaphit-injected animals expressing epilepsy with a maximum incidence and seizure severity after the 8th AGS received DSIP and its analogue. Time course studies revealed a mild incidence reduction of all convulsion components occurring about 1-5 h after DSIP and DSIP À12 injection. After the appearance of all convulsive components, DSIP and DSIP À12 significantly reduced running activity in comparison with only metaphit group, at the same checkpoints: 25 h (P < 0.05) after metaphit administration, DSIP À12 expressed more potent blocking effect in reduction of convulsive responses in comparison with DSIP and the difference was statistically significant (A versus D); for running 10 h (P < 0.05) and 11 h (P < 0.05) after metaphit administration; for tonic convulsive responses 9 h (P < 0.05) and 13 h (P < 0.05) ( Table 1 ). In metaphit + DSIP and metaphit + DSIP À12 group the mean seizure grade had most prominent reduction 1 h (P < 0.05, U = 16.50) and 3 h (P < 0.05, U = 18.00) after injection of DSIP or its analogue (Table 2) .
In addition to the differences in convulsive response, the groups also differed in duration of several aspects of seizure components. Mean duration of tonic component in group A was significantly reduced 12 h [ F(8.29) = 10.90, P < 0.01] and 13 h [ F(8.29) = 6.90, P < 0.01], after metaphit injection in comparison with metaphit group (Fig. 3) .
EEG activity characteristic for metaphit epileptic action (synchronized spikes) was overlapped with bursts of high amplitude EEG in the 5-10 Hz range (d and u frequencies). There were increases of the sequential power spectra particularly in d and u frequency bands (Fig. 4) .
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Discussion and conclusions
The results of the present study demonstrate that DSIP and DSIP À12 act by increasing the EEG output in the d range and decreasing the incidence and duration of convulsive component, as well as mean seizure grade in metaphit-induced seizures. We showed previously 9 that the dose of 1 mg DSIP/kg acted by increasing the EEG output in the d range and significantly elevating the mean power spectra in comparison with the control group.
Several studies have indicated that DSIP and its analogues might be representing more than a sleeppeptide. 6, 8, [10] [11] [12] [13] One of them, DSIP À12 , with an increased resistance against proteolytic action and elevated lipophilicity, has been proven to penetrate through the blood-brain barrier and to alleviate corazole-induced convulsions. 8 In forms of acute generalized epilepsy induced by picrotoxin, corazole, 8 bicuculine, thiosemicarbazide, strychnine, N-methyl-D-aspartic acid, pentylenetetrazole, 10, 11 and metaphit, 2,14 DSIP had neuroprotective and antiepileptic role. It has been observed that DSIP and b-endorphin increase seizure threshold during night period in the pentylene-tetrazole epilepsy and express neuroprotective effect. 15 A single i.p. DSIP injection acts by preventing the development of epileptic activity due to creation of optimal monoamine levels in brain structures. 16 Its effects are manifested via reduction of excitatory neurotransmitter amino acids (glutamate, aspartate) and at the same time, via dramatic increase in g-aminobutyric acid and homocarnosine content. 16, 17 On the other hand, modulatory effect of DSIP is manifested through the regulation of the number of glutamate receptors (NMDA) and limited effect of this excitatory neuromediator. 11 We hypothesized an existence of a certain unspecific DSIP action on NMDA receptor complex. It is said that both presynaptic glutamate and Ca 2+ influx through postsynaptic membrane are decreased while synthetic rate of NO (a retrograde messenger) is reduced due to DSIP administration, consequentially leading to a decline of glutamate release and epileptic manifestation. 18, 19 Though sleep and epilepsy have many properties in common (e.g. spontaneously, recurring event and EEG hypersynchronization including EEG potentials that look very similar to epileptiform sharp waves), sleep is not epilepsy. 20 The relationship between sleep and epilepsy is reciprocal. Rapid eye movement (REM) sleep represents the most antiepileptic state in the sleep-wake cycle 21, 22 and deprivation of REM sleep has been observed to reduce seizure thresholds. 23, 24 On the other hand, synchronized 246 O.P. Stanojlović et al. discharge and sleep spindles that characterize slow wave sleep (SWS) were reported to favor epilepsy. 25 Metaphit in a dose of 10 mg/kg i.p. has been observed to induce audiogenic seizures after systemic and intracerebroventricular administration and to be truly epileptic in small rodents with EEG paroxysmal activity and spike-wave complexes. [1] [2] [3] [4] [5] Our data presented here is in accordance with the results of Shandra et al., 11 who suggested that DSIP plays a neuroprotective role against excitatory N-methyl-D-aspartic acid which shares the same receptor with metaphit, although they bind to different binding sites. Earlier available data and our results support the idea that DSIP could represent one of the factors of the endogenous stabilization of brain excitability. Structural DSIP's analogue, DSIP À12 , under identical experimental conditions acted as more potent antiepileptic in generalized metaphit-induced convulsive activity. All aforementioned data, 8, 11, 17 together with our results demonstrating higher efficiency of DSIP À12 in comparison with DSIP supports the idea that DSIP À12 may be considered to have antiepileptic action.
